Danaher Profile



Odds of Distress

Equity ratings for Danaher Corporation are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 10, 2019 and ending today December 9, 2019. Click here to learn more.

Danaher Profile

Next fiscal quarter end is expected on December 31, 2019. The stock is currently experiencing above average trading activities. Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia. Danaher operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 71000 people. more
Danaher Fama & French Measuring and Control Equipment
Measuring and Control Equipment
Fama & French Classification
Danaher SEC Filings
Danaher SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameDanaher Corporation
CEOThomas JoyceView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Diagnostics & Research
InstrumentUSA Stock View All
RegionNorth America
LocationDistrict Of Columbia; U.S.A
Business Address2200 Pennsylvania Avenue N.W., Suite 800W, Washington, DC 20037-1701, United States
ExchangeBATS Exchange
CIK Number0000313616
Older SymbolDHR-PA
IndustryDiagnostics & Research
Phone202 828 0860
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterSeptember 27, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestNovember 15, 2019
Danaher Corporation (DHR) is traded on BATS Exchange in USA. It is located in 2200 Pennsylvania Avenue N.W., Suite 800W, Washington, DC 20037-1701, United States and employs 71,000 people. Danaher Corporation was also traded as Danaher Corporation 4 75 Percent Manda on New York Stock Exchange under the symbol DHR-PA. Danaher is listed under Measuring and Control Equipment category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 105.97 B. Danaher runs under Healthcare sector within Diagnostics & Research industry. The entity has 718.28 M outstanding shares of which 4.71 M shares are currently shorted by investors with about 1.73 days to cover shorted positions. DANAHER CP has about 14.25 B in cash with 3.07 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.84.
Check Danaher Probability Of Bankruptcy

Ownership Allocation (%)

Danaher Target Price Odds Analysis

Odds Below 147.53HorizonTargetOdds Above 147.53
95.72%30 days 147.53 4.19%
Based on normal probability distribution, the odds of Danaher to move above current price in 30 days from now is nearly 4.19 (This Danaher Corporation probability density function shows the probability of Danaher Stock to fall within a particular range of prices over 30 days) .

Danaher Top Holders

Danaher Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares49.1 M7.1 B
Blackrock IncCommon Shares46.1 M6.7 B
View Danaher Diagnostics

Danaher Corporation Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Danaher Key Fundamentals

Danaher Against Markets

Did you try this?

Run Analyst Recommendations Now


Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

Danaher Upcoming and Recent Events

Danaher Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 4, 2020
Next Earnings ReportApril 16, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 4, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Danaher Corporate Filings

Danaher SEC Reporting

Financial Statements and Exhibits. Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
Unclassified Corporate Event
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Results of Operations and Financial Condition

Danaher Distributions to stockholders

Danaher Corporate Directors

Robert Hugin Director
John Schwieters Independent Director
Linda Filler Independent Director
Additionally see Investing Opportunities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Search macroaxis.com